Craneware plc (AIM:CRW)
London · Delayed Price · Currency is GBP · Price in GBX 1,460.00
+6.00 (0.41%)
May 27, 2026, 4:38 PM GMT
Craneware Market Cap
Craneware has a market cap or net worth of 493.2 million as of May 27, 2026. Its market cap has decreased by -27.40% in one year.
Market Cap
493.20M
Enterprise Value
482.76M
Revenue
157.02M
Ranking
n/a
PE Ratio
31.16
Stock Price
1,460.00
Market Cap Chart
Since September 13, 2007, Craneware's market cap has increased from 27.00M to 493.20M, an increase of 1,726.98%. That is a compound annual growth rate of 16.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 493.20M | -27.14% |
| Dec 31, 2025 | 676.88M | -8.39% |
| Dec 31, 2024 | 738.88M | 20.69% |
| Dec 29, 2023 | 612.23M | -3.93% |
| Dec 30, 2022 | 637.29M | -26.03% |
| Dec 31, 2021 | 861.52M | 41.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.84B |
| GSK plc | 76.45B |
| Haleon | 30.46B |
| Smith & Nephew | 9.72B |
| Spire Healthcare Group | 891.33M |
| CVS Group | 841.18M |
| Oxford Biomedica | 747.29M |
| Allergy Therapeutics | 569.93M |